Yunnan Botanee Bio-Technology Group Co.LTD (300957.SZ)
CNY 41.13
(4.55%)
CNY 41.13
(4.55%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.01 Billion CNY | -36.32% |
| 2022 | 1.3 Billion CNY | 22.9% |
| 2021 | 1.09 Billion CNY | 56.47% |
| 2020 | 663.71 Million CNY | 19.2% |
| 2019 | 515.53 Million CNY | 55.99% |
| 2018 | 325.96 Million CNY | 62.72% |
| 2017 | 199.08 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 329.43 Million CNY | 117.15% |
| 2024 Q1 | 181.34 Million CNY | -35.87% |
| 2024 Q3 | -65.85 Million CNY | -116.72% |
| 2023 Q1 | 117.41 Million CNY | -84.08% |
| 2023 FY | - CNY | -36.32% |
| 2023 Q4 | 181.09 Million CNY | 0.76% |
| 2023 Q2 | 365.78 Million CNY | 211.52% |
| 2023 Q3 | 179.73 Million CNY | -50.86% |
| 2022 Q3 | 101.13 Million CNY | -62.41% |
| 2022 Q2 | 269.05 Million CNY | 99.77% |
| 2022 Q1 | 134.68 Million CNY | -76.69% |
| 2022 Q4 | 737.55 Million CNY | 629.3% |
| 2022 FY | - CNY | 22.9% |
| 2021 Q4 | 577.71 Million CNY | 361.07% |
| 2021 Q2 | 227.66 Million CNY | 134.13% |
| 2021 Q1 | 97.24 Million CNY | 112.52% |
| 2021 FY | - CNY | 56.47% |
| 2021 Q3 | 125.29 Million CNY | -44.96% |
| 2020 Q3 | 485.44 Million CNY | 269.39% |
| 2020 Q2 | 131.41 Million CNY | 105.73% |
| 2020 Q1 | 63.87 Million CNY | 111.2% |
| 2020 FY | - CNY | 19.2% |
| 2020 Q4 | -776.47 Million CNY | -259.95% |
| 2019 Q3 | 362.22 Million CNY | 0.0% |
| 2019 FY | - CNY | 55.99% |
| 2019 Q4 | -570.58 Million CNY | -257.52% |
| 2018 FY | - CNY | 62.72% |
| 2017 FY | - CNY | 0.0% |